Casma Therapeutics

About:

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

Website: https://www.casmatx.com/

Twitter/X: casmatx

Top Investors: Third Rock Ventures, Schroders Capital, The Column Group, Eventide, Mirae Asset

Description:

Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.